Johnson and Johnson paused the stage 3 trial after a participant developed an unexplained illness as the Lancet confirmed reinfection in a 25-year-old Nevada man without underlying conditions
LEARN MORE:
Judge strikes down attempt to stop mask mandate
as cases continue to rise in Wisconsin:
#ABCNews #JohnsonandJohnson #Johnson&Johnson #COVIDVaccine
